Delivery Order SPE2DX22D0010-SPE2D825FDW42
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$5.1K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR Oral Suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $6,727.50 and an ultimate completion date of November 3, 2023. The contract is a firm fixed-price delivery order and is...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,820.37 contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The delivery order has an ultimate completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,327.20 firm fixed-price contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 24, 2023 and was awarded on November 22, 2023. This delivery order is part...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,343.11 and is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm fixed-price delivery order with a period of performance through February 18, 2025. It is not designated as a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,604.50 and is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used to treat ADHD. The contract is a Firm Fixed Price Delivery Order with a completion date of February 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,628.40, is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.05 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,293.58 firm fixed-price contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. It is not designated as a set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,083.07 and a completion date of February 14, 2025. It is a firm fixed-price contract for the supply of Quillivant XR Oral Suspension, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.73 firm-fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract, which has an ultimate completion date of October 30, 2024, is a part of a larger Indefinite Delivery Contract (IDC) between...